CN105311569A - Medicine for treating hyperplasia of prostate gland - Google Patents
Medicine for treating hyperplasia of prostate gland Download PDFInfo
- Publication number
- CN105311569A CN105311569A CN201510801223.2A CN201510801223A CN105311569A CN 105311569 A CN105311569 A CN 105311569A CN 201510801223 A CN201510801223 A CN 201510801223A CN 105311569 A CN105311569 A CN 105311569A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- herba
- rhizoma
- radix morindae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating hyperplasia of prostate gland. The medicine is prepared from the following medicinal raw materials in parts by weight: 10 parts of fructus rubi, 8 parts of herba cynomorii, 8 parts of Chinese starjasmine stem, 9 parts of rhizoma curculiginis, 11 parts of herba patriniae, 12 parts of rhizoma curcumae, 15 parts of fruit of Chinese wolfberry, 9 parts of radix morindae officinalis and 10 parts of cordyceps sinensis. According to the medicine disclosed by the invention, the fructus rubi is capable of securing essence and reducing urination; the herba cynomorii is effective on tonifying yang and arresting seminal emission; the Chinese starjasmine stem serves as cooling blood and relieving swelling; the rhizoma curculiginis is beneficial for warming kidney and tonifying yang; the herba patriniae functions as eliminating pus and dissolving carbuncle; the rhizoma curcumae is used for removing stagnation and relieving pain; the fruit of Chinese wolfberry is capable of nourishing liver and kidney; the radix morindae officinalis is capable of invigorating kidney and reinforcing tendons; and the cordyceps sinensis is capable of replenishing essence and invigorating qi. The medicine, which combines the various medicinal materials in use, can achieve functions of tonifying kidney and nourishing liver, tonifying yang and promoting diuresis, and the medicine can be used for effectively treating the hyperplasia of prostate gland. Upon clinical experiments, the medicine disclosed by the invention can safely and effectively treat the hyperplasia of prostate gland.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of prostatic hyperplasia.
Background technology
Prostatic hyperplasia is one of middle-aging male common disease, its feature shows as body of prostate, smooth muscle and proliferation of fibrous tissue and causes prostate non-malignant proliferative to sexually revise, and then compressing holds urethra and produces a series of lower urinary tract obstruction such as urine retention, urinary tract infection comprehensive complication, be mainly in 5O year above middle-aging male.
Prostatic hyperplasia early stage due to compensatory, atypical symptom, along with lower urinary tract obstruction increases the weight of, symptom is obvious gradually, and clinical symptoms comprises: 1. urine storage phase symptom (1) frequent micturition, nocturia increase (2) urgent micturition, urinary incontinence.2. to urinate phase symptom dysuria.3. post micturition symptoms urine retention, residual urine increase.4. the long-term lower urinary tract obstruction of other symptoms (1) hematuria (2) urinary system infection (3) vesical calculus (4) renal function injury (5).
Current doctor trained in Western medicine clinical treatment prostatic hyperplasia there is no active drug, multiselect minimal invasive operation.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of prostatic hyperplasia, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing prostatic hyperplasia.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of medicine being used for the treatment of prostatic hyperplasia, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Fructus Rubi 10 parts, Herba Cynomorii 8 parts, Caulis Trachelospermi 8 parts, Rhizoma Curculiginis 9 parts, Herba Patriniae 11 parts, Rhizoma Curcumae 12 parts, Fructus Lycii 15 parts, Radix Morindae Officinalis 9 parts, Cordyceps 10 parts.
Inventor thinks: the stagnation of QI of suffering from a deficiency of the kidney, essence and blood is obstructed.Noxious dampness alluvial external genitals, cause QI and blood to block, glandular hyperplasia, essence, gas, water can not normal excretion.
The present invention uses: Fructus Rubi controlling nocturnal emission with astringent drugs reducing urination; The emerging positive controlling nocturnal emission with astringent drugs of Herba Cynomorii; Caulis Trachelospermi removing heat from blood is subsided a swelling; Rhizoma Curculiginis warming the kidney to invigorate YANG; The evacuation of pus of Herba Patriniae eliminating carbuncle; The pain relieving of Rhizoma Curcumae removing food stagnancy; Fructus Lycii nourishing the liver and kidney; The strong muscle of Radix Morindae Officinalis the kidney invigorating; Cordyceps replenishing vital essence and invigorating vital QI.All medicines share, and play kidney tonifying nourishing the liver altogether, and YANG invigorating leads to effect of urine, effectively treats prostatic hyperplasia.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects Patients with Prostatic Hyperplasia 70 example for 2012 altogether between year December of December ~ 2014, all from urology department outpatient service, at 50 ~ 80 years old age, be male.The course of disease 0.5 year ~ 6 years.
Diagnostic criteria: with reference to State Administration of Traditional Chinese Medicine " disease of tcm Standardization of diagnosis and curative effect "
(1) start frequent micturition, especially nocturia increased frequency, gradually has dysuria, remaining drown endless, urine retention or urinary incontinence can be had time serious.(2) primary disease is more common in elderly men.(3) rectal touch: prostate hyperplasia, smooth surface and without tuberosity, clear-cut margin, medium hardness and high resilience, Rolandic fissure shoals or disappears.(4) ultrasound diagnosis: prostate size measurement compared with normal increases, and bladder remains urine and is greater than 60mL.
Meet above-mentioned diagnostic criteria, the patient that the age is greater than 18 years old.
Exclusion standard: merge serious cardiopulmonary hepatorenal disease person.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.10 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
With reference to " disease of tcm Standardization of diagnosis and curative effect " and " traditional Chinese medical science andrology Illnesses Diagnoses and the standard of curative effect evaluation "
(1) cure: unobstructed micturition, prostatic examination is obviously reduced, without residual urine.
(2) effective: symptom of urinating is clearly better, and residual urine obviously reduces.
(3) effective: symptom of urinating takes a turn for the better, residual urine reduces.
(4) invalid: symptom and every inspection all without improvement, even increase the weight of.
3.2 therapeutic outcome
70 routine patients cure 32 examples, effective example 22, effective 11 examples, invalid 5 examples, total effective rate 92.8%.There is laxativeness in treatments period 1 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of prostatic hyperplasia, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Fructus Rubi 10 grams, Herba Cynomorii 8 grams, Caulis Trachelospermi 8 grams, Rhizoma Curculiginis 9 grams, Herba Patriniae 11 grams, Rhizoma Curcumae 12 grams, Fructus Lycii 15 grams, Radix Morindae Officinalis 9 grams, Cordyceps 10 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of prostatic hyperplasia.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Fructus Rubi 10 grams, Herba Cynomorii 8 grams, Caulis Trachelospermi 8 grams, Rhizoma Curculiginis 9 grams, Herba Patriniae 11 grams, Rhizoma Curcumae 12 grams, Fructus Lycii 15 grams, Radix Morindae Officinalis 9 grams, Cordyceps 10 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of prostatic hyperplasia.Oral, daily once.
Embodiment 3
Take: Fructus Rubi 10 grams, Herba Cynomorii 8 grams, Caulis Trachelospermi 8 grams, Rhizoma Curculiginis 9 grams, Herba Patriniae 11 grams, Rhizoma Curcumae 12 grams, Fructus Lycii 15 grams, Radix Morindae Officinalis 9 grams, Cordyceps 10 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of prostatic hyperplasia.Oral, every bu is taken for twice sooner or later.
Claims (4)
1. one kind is used for the treatment of the medicine of prostatic hyperplasia, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Fructus Rubi 10 parts, Herba Cynomorii 8 parts, Caulis Trachelospermi 8 parts, Rhizoma Curculiginis 9 parts, Herba Patriniae 11 parts, Rhizoma Curcumae 12 parts, Fructus Lycii 15 parts, Radix Morindae Officinalis 9 parts, Cordyceps 10 parts.
2. be used for the treatment of the medicine of prostatic hyperplasia as claimed in claim 1, it is characterized in that, its preparation method is: take: Fructus Rubi 10 parts, Herba Cynomorii 8 parts, Caulis Trachelospermi 8 parts, Rhizoma Curculiginis 9 parts, Herba Patriniae 11 parts, Rhizoma Curcumae 12 parts, Fructus Lycii 15 parts, Radix Morindae Officinalis 9 parts, Cordyceps 10 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of the medicine of prostatic hyperplasia as claimed in claim 1, it is characterized in that, its preparation method is: take: Fructus Rubi 10 parts, Herba Cynomorii 8 parts, Caulis Trachelospermi 8 parts, Rhizoma Curculiginis 9 parts, Herba Patriniae 11 parts, Rhizoma Curcumae 12 parts, Fructus Lycii 15 parts, Radix Morindae Officinalis 9 parts, Cordyceps 10 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of the medicine of prostatic hyperplasia as claimed in claim 1, it is characterized in that, its preparation method is: take: Fructus Rubi 10 parts, Herba Cynomorii 8 parts, Caulis Trachelospermi 8 parts, Rhizoma Curculiginis 9 parts, Herba Patriniae 11 parts, Rhizoma Curcumae 12 parts, Fructus Lycii 15 parts, Radix Morindae Officinalis 9 parts, Cordyceps 10 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510801223.2A CN105311569A (en) | 2015-11-19 | 2015-11-19 | Medicine for treating hyperplasia of prostate gland |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510801223.2A CN105311569A (en) | 2015-11-19 | 2015-11-19 | Medicine for treating hyperplasia of prostate gland |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105311569A true CN105311569A (en) | 2016-02-10 |
Family
ID=55240525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510801223.2A Pending CN105311569A (en) | 2015-11-19 | 2015-11-19 | Medicine for treating hyperplasia of prostate gland |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105311569A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007143A (en) * | 2006-11-23 | 2007-08-01 | 姚素英 | A traditional Chinese medicine for treating prostate diseases |
| CN103028083A (en) * | 2012-12-05 | 2013-04-10 | 纪瑞 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
-
2015
- 2015-11-19 CN CN201510801223.2A patent/CN105311569A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007143A (en) * | 2006-11-23 | 2007-08-01 | 姚素英 | A traditional Chinese medicine for treating prostate diseases |
| CN103028083A (en) * | 2012-12-05 | 2013-04-10 | 纪瑞 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100531768C (en) | Medicament for treating chronic prostatitis and prostatic hyperplasia | |
| CN102579897B (en) | Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof | |
| CN101862428B (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN102210753B (en) | Traditional Chinese medicine composition for treating lithiasis in urinary system | |
| CN101732602B (en) | Medicament for treating calculi and preparation method thereof | |
| CN103110763B (en) | Traditional Chinese medicine composition for treating urinary calculus and preparation method thereof | |
| CN104587252A (en) | Traditional Chinese medicine composition for treating kidney stones | |
| CN103585585A (en) | Traditional Chinese medicine composition for treating choledocholithiasis and preparation method thereof | |
| CN105311569A (en) | Medicine for treating hyperplasia of prostate gland | |
| CN104127827A (en) | Traditional Chinese medicine for treating biliary calculi | |
| CN101461841B (en) | Chinese patent medicine for treating prostatoplasia | |
| CN104398949A (en) | Traditional Chinese medicine oral liquid for treating prostatitis | |
| CN109602838A (en) | A kind of Chinese medicine composition and its preparation method and application for treating chronic inflammation | |
| CN114246931B (en) | External application preparation for treating winter diseases in summer and preparation method thereof | |
| CN102846744A (en) | Drug for treating prostatic hypertrophy | |
| CN101057921B (en) | Traditional Chinese medicine capsule for treating prostatic hyperplasia | |
| CN101244227B (en) | Chinese medicine pill mainly for treating nephropathy | |
| CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
| CN105148050A (en) | Traditional Chinese medicinal composition for treating kidney stone | |
| CN106266970B (en) | A kind of Chinese medicine composition treated production and cause endometritis | |
| CN105687865A (en) | Traditional Chinese medicine composition for treating stranguria | |
| CN1331519C (en) | Calculi resolving capsule and its preparing method | |
| CN102698190B (en) | Traditional Chinese medicine for treating irritable bowel syndrome | |
| CN102836343B (en) | Medicine for colon nursing and colitis treatment | |
| CN103768316A (en) | Traditional Chinese medicine composition for treating kidney-yang deficiency enterophthisis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160210 |
|
| WD01 | Invention patent application deemed withdrawn after publication |